| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $42.2M | -84.2% |
| Cost of Revenue | $13.8M | -88.2% |
| R&D Expense | $108.9M | +16.7% |
| SG&A Expense | $100.6M | -40.0% |
| Operating Income | -$181.1M | -62.2% |
| Interest Expense | $9.0M | -66.9% |
| Pre-tax Income | -$183.1M | -742.4% |
| Income Tax | $0 | — |
| Net Income | $168.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $88.9M | -29.5% |
| Short-term Investments | $83.2M | — |
| Accounts Receivable | $17.8M | -84.0% |
| Inventory | $3.2M | -95.5% |
| Current Assets | $206.7M | -39.5% |
| Total Assets | $258.3M | -42.4% |
| Current Liabilities | $140.4M | -50.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$138.5M | -577.7% |
| Investing Cash Flow | $375.1M | +62.9% |
| Financing Cash Flow | -$273.7M | -46.4% |
| +489.4% |
| EPS (Basic) | $1.43 | +472.0% |
| EPS (Diluted) | $1.43 | +472.0% |
| Total Liabilities |
| $197.3M |
| -66.0% |
| Stockholders' Equity | $61.0M | +146.2% |